Use of Immunosuppressive Therapy for Sarcoidosis

University of Cincinnati

Status: Unknown

Conditions: Sarcoidosis

Treatments: Other: Cytotoxic drug

Study type: Observational

Funder types: Other

Identifiers

NCT02356445

UCincinnati

Details and patient eligibility

About

Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis

Full description

Patients receiving one or more cytotoxic or other immunosuppressive drug will be observed

Enrollment: 2,000 estimated patients

Sex: All

Ages: 15 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Any patient treated for sarcoidosis

Exclusion criteria

• None

Trial design

2,000 participants in 1 patient group

Cytotoxic drug

Description:

Patients treated for sarcoidosis

Treatment:

Other: Cytotoxic drug